Institut De Cancerologie De L Ouest — Clinical Trial Site

441 Registered trials

258 Currently recruiting

Organisation

Institut De Cancerologie De L Ouest

Location

Saint-Herblain Cedex, France

Identifier

ORG-100010298

Address

Boulevard Jacques Monod, 44805, France

Departments

#1000: Medical Oncology
#1205: Medecine Nucleaire
#2160: Radiology
#3507; Medical Oncology
033001:Oncology
03310: Oncology
1001:Medecine nucleaire
1205: Oncologie Médicale
1207: Medecine Nucleaire
1306: Departement d'oncologie Medicale/Unite de Developpement des Therapeutiques Precoces
2105:Oncology
2301 Oncology Medical
2303:Service Oncologie Medicale
2304: Medical Oncology
2309 Oncology Medical
250004:Oncology
250009: Département d'Oncologie
301: Medical Oncology
3097:Oncology
3201:Medical Oncology
33005: Oncologie Médicale
4001: Oncologie
402 : Medical Oncology
4407:Medical Oncology
Anesthésie Douleur
Cardiology
Centre d'investigation Clinique Thorax (équipe Cardiovasculaire
Chirurgie Digestive
Chirurgie gynécologique
Chirurgie Oncologique Gynécologique
Département d'anesthésiologie, et médecine de la douleur
Departement d'Oncologie
Departement d'oncologie - radiotherapie
Département d'Oncologie Médicale
Département d’oncologie médicale
Département d’oncologie médicale- sénologie et neuro-oncologie Unité des thérapeutiques précoces
Département de radiothérapie
Dermatology
digestif
Digestive Oncology
Digestive surgery
Early Therapeutics Development Unit
FRA003: Servce d'Oncologie Médicale
FRA03-0: Medical Oncology
Gynaecologic Oncology
Gynecologie
Gynecologie medicale
Hepatogastroenterology
Institut de Cancérologie de l’Ouest
Institut de Cancérologie de l’Ouest Saint Herblain
Maine-et-Loire
Medecine nucleaire
medecine nuclear department
Medical
Medical Oncologist
medical oncology
Medical Oncology Department
Medical Oncology Departmet
N/A
NA
Nuclear Medicine
Oncogénétique
Oncolgie
Oncologie
Oncologie Médicale
Oncologie Chirurgie et Anesthesie
Oncologie digestive
Oncologie Médical
Oncologie médicale
Oncologie médicale - essais précoces
ONCOLOGIE OPTION MEDICALE
Oncologie Radiothérapie
Oncologue
Oncology
Oncology clinic
Oncology department
Oncology medical
pneumology
Pulmonary Oncology
Radiothérapie
Radiotherapist
Radiotherapy
Radiotherapy Departement
Radiotherapy department
Radiotherapy for pediatrics and adults
Service d' Oncologie Médicale
Service d'ocologie
Service d'Oncologie
Service d'Oncologie Médicale
Service d’Oncologie Médicale
Service de Cancérologie
Service de Chirurgie Digestive
Service oncologie
Service Oncologie médicale
Service Oncologie-Radiothérapie
Site de SAINT-HERBLAIN - Département d'Oncologie Médicale
Site René Gauducheau
Supportive care
Surgery
Surgical Oncology

Clinical trials at this site (441)

Search interface

Induction chemotherapy followed by standard concurrent chemoradiotherapy in cervical cancer with para-aortic lymph node involvement: A phase… Halted

2024-513576-18-00 Cervical Cancer 5 2020-07-17
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together with Either Pembrolizumab, Standard Therapies, or Both, in Adults with Solid T… Ended

2023-505084-37-00 Advanced Solid Tumors 7 2025-03-17
AKTive-001: A Phase 1/1b Multiple Cohort Trial of ALTA2618 in Patients with Advanced Solid Tumors with AKT1 E17K Mutation Ended

2024-515391-12-00 Advanced Solid Tumors with AKT1 E17K Mutation 1 2025-03-15
Study of Repotrectinib and CYP450 probe Cocktail in Patients with locally advanced or Metastatic Tyrosine Kinase Inhibitors (TKI)-Pretreated… Ended

2024-511030-12-00 Non-small Cell Lung Cancer (NSCLC) 3 2025-02-03
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole Compared to Letrozole Alone in Postmenopausal Wom… Ended

2024-512848-30-00 HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER 4 2024-11-12
Perioperative Treatment in Resectable Gastric Cancer with Spartalizumab (PDR001) in Combination with fluorouracil, leucovorin, oxaliplatin, … Ended

2024-516299-13-00 Resectable Gastric Cancer 4 2024-09-06
A Phase 1 Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation Ended

2023-503223-26-00 Advanced Solid Tumors Harboring a KRASG12C Mutation 9 2024-05-07
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer Ended

2023-504630-22-00 Non-Small Cell Lung Cancer 7 2024-04-19
TACTIVE-U: An Umbrella Study to Investigate the Safety and Antitumor Activity of vepdegestrant (ARV-471) in Combination With Other Medicines… Ended

2023-507125-41-00 Advanced or Metastatic Breast Cancer 9 2024-03-25
A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-A3… Ended

2023-505322-34-00 Advanced or metastatic solid tumors 1 2024-01-08
A Dose Escalation and Cohort Expansion Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors or Non-Hodgkin Lymphoma. Ended

2023-503739-16-00 Relapsed or refractory solid tumors or non-Hodgkin lymp 1 2023-12-20
Study comparing radiotherapy combined with cetuximab + Xevinapant (study drug) with radiotherapy combined with cetuximab + placebo in patien… Ended

2022-502584-38-00 Locally advanced squamous cell carcinoma of the head an 5 2023-12-12
Study of ART0380 in Advanced/Metastatic Solid Tumors Patients (ARTIST) Ended

2023-504153-12-00 Advanced or Metastatic Solid Tumors 4 2023-12-07
Randomized, non-comparative, open-label early phase Ib study with OBT076 or OBT076 followed by Balstilimab in patients with Adenoid Cystic C… Ended

2023-503270-20-00 recurrent or metastatic Adenoid Cystic Carcinoma of the 3 2023-11-29
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma Ended

2023-503418-63-00 Head and Neck Squamous Cell Carcinoma 4 2023-11-23
AN OPEN-LABEL, MULTICENTER, PHASE 1a/1b STUDY OF IGM-8444 AS A SINGLE AGENT AND IN COMBINATION IN SUBJECTS WITH RELAPSED, REFRACTORY, OR NEW… Ended

2023-504545-31-00 colorectal cancer 1 2023-11-23
A study to test the effect of Samuraciclib in Combination with Elacestrant in Participants with Hormone Receptor-positive (HR+) and Human Ep… Ended

2023-503846-30-00 Breast Cancer 9 2023-10-10
Phase II, multi‑cohort trial of neoadjuvant and post‑surgery IO102‑IO103 and pembrolizumab in patients with selected resectable tumors Ended

2022-502787-20-00 Melanoma and squamous cell carcinoma of the head and ne 4 2023-09-28
A study to investigate response to ompenaclid combined with FOLFIRI plus bevacizumab in patients with advanced or metastatic colorectal canc… Ended

2023-503356-27-00 Metastatic colorectal cancer that is resistant to the c 4 2023-09-07
Phase 2/3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer Ended

2022-502196-31-00 Advanced or Recurrent Endometrial Cancer 10 2023-08-21
Clinical trial of MK-7648A in adults and children with skin cancer Ended

2022-501417-31-01 melanoma 5 2023-08-01
A Multicenter, Open-label Phase 1/2 Study of TYRA 300 in Advanced Urothelial Carcinoma and Other Solid Tumors Ended

2023-507589-22-00 Advanced Urothelial Carcinoma and Other Solid Tumors wi 7 2023-07-28
A Study of TAK-676 as Single Agent and TAK-676 in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors Ended

2023-505627-30-00 Solid Neoplasm 7 2023-07-26
OMX-0407 Phase I Study Ended

2024-514554-75-00 Previously treated unresectable solid tumours 1 2023-03-16